API Raw material powder Tirzepatide 99% High-quality weight loss peptides

Name:Niki

Whatsapp:+86 15030922776

Email niki@xtmingheng.com

The product introduction of Tirz (usually referred to as Tirzepatide) is as follows:
Trade names: Tirzepatide (used to improve blood pressure in patients with type 2 diabetes), Tirzepatide (used to lose weight)
R&D company: Eli Lilly and Company
Type of drug: New insulin glucagon-like peptide-1 (GLP-1) and insulinotropic insulin (GIP) dual aspirin
Mechanism of action: By activating GLP-1 and GIP blood pressure, stimulating insulin, lowering blood pressure, while delaying gastric emptying and blood pressure, thereby controlling weight.

Improve blood sugar in adults with type 2 diabetes.
As a weight loss drug for adults who are obese (BMI 30 or above) or overweight (BMI 27 or above but with at least one weight-related comorbidity, such as hypertension, type 2 diabetes, or high cholesterol), with Manage your weight by reducing dietary calories and increasing exercise.

Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.

Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.



Subcutaneous injection.
The recommended starting dose is 2.5 mg subcutaneously once weekly, increasing to 5 mg after 4 weeks, and then in 2.5 mg increments based on treatment response and tolerance, up to a maximum dose of 15 mg subcutaneously once weekly.
Can be taken at any time of day, with or without food, into the abdomen, thigh, or upper arm, rotating the injection site with each injection.

Xingtai xinkaiyue Technology Co., Ltd. was founded in 2019 has strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures. We effectively promote joint ventures and cooperation with major enterprises and manufacturers, and serve the society and the majority of users with the idea of industrialized development. We always adhere to the market demand-oriented, and constantly synthesize new chemical products and pharmaceutical intermediates with high technical content, mainly exported to the United States, India, South Africa, Nigeria and many other countries and regions, with rich experience in export, to ensure the safety of transportation, and to be able to let every customer receive the goods safely as early as possible.

OPTIMIZED, AUTOMATED HIGH-YIELD PRODUCTION

Should be stored in the refrigerator at 2°C to 8°C, away from light.

If required, each single-dose pen can be stored unrefrigerated at a temperature not exceeding 30°C for up to 21 days, but once stored at room temperature it should not be returned to the refrigerator. If not used within 21 days after removal from the refrigerator, it should be discarded. Do not freeze tilpotide and if frozen, do not use.